✦ LIBER ✦

Treatment of chronic active type B hepatitis (CABH). A pilot study. (I)

✍ Scribed by Herreries, JM; Valladolid, JM; Villarrubia, VG; Jiménez, M; Sada, G; Vilchez, JG; Elorza, FL

Book ID: 121993683
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 102 KB
Volume: 11
Category: Article
ISSN: 0168-8278
DOI: 10.1016/0168-8278(90)91699-W

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Isoprinosine in the Treatment of Chronic

Isoprinosine in the Treatment of Chronic Active Hepatitis Type B

✍ Cianciara, Janusz; Laskus, Tomasz; Gabinska, Elzbieta; Loch, Teresa 📂 Article 📅 1990 🏛 Informa plc 🌐 English ⚖ 266 KB

Treatment of chronic non-A, non-B hepati

Treatment of chronic non-A, non-B hepatitis with acyclovir: Pilot study

✍ S. Chris Pappas; Dr. Jay H. Hoofnagle; Neal Young; Stephen E. Straus; E. Anthony 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

Five patients with chronic non-A, non-B hepatitis were entered into a pilot therapeutic study of the antiviral agent acyclovir [9-(2-hydroxyethoxymethyl) guanine]. Each patient received acyclovir by slow intravenous infusion in a dosage of 5 mg/kg every 8 hr for 10 days. During therapy, serum aminot

Oral ganciclovir treatment in chronic he

Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilot study

✍ Stephanos J Hadziyannis; Emanuel K Manesis; Anastasia Papakonstantinou 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 634 KB

Immunomodulatory activities of AM3 appea

Immunomodulatory activities of AM3 appear to be related with its positive effects on chronic type B hepatitis (CABH).(II)

✍ Elorza, FL; Valladolid, JM; Vilchez, JG; Jiménez, N; Sada, G; Herrerias, JM; Vil 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Pilot study of recombinant human interle

Pilot study of recombinant human interleukin 2 for chronic type B hepatitis

✍ Shinichi Kakumu; Akihiko Fuji; Kentaro Yoshioka; Hirofumi Tahara; Yoshiyuki Ohta 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

Recombinant human interleukin 2 was administered to 10 patients with chronic type B hepatitis as a part of a pilot study to evaluate its antiviral activity. Patients received 1 to 3 x 10' units per day of interleukin 2 for 21 to 28 days, and all completed the treatment schedule. During therapy, seru

A pilot study of 2′,3′-dideoxyinosine fo

A pilot study of 2′,3′-dideoxyinosine for the treatment of chronic hepatitis B

✍ Michael W. Fried; Julia C. Korenman; Adrian M. Di Bisceglie; Yoon Park; Jeanne G 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 1 views

The nucleoside analog 2',3'-dideoxyinosine, currently being used to treat patients infected with the human immunodeficiency virus, has been shown to inhibit viral replication in certain cell culture systems of hepatitis B virus and the duck model of chronic hepatitis B infection. We studied the effe